Rash Developing after Cessation of Daclizumab for Relapsing Remitting MS; A Case Series
We present three patients who developed urticarial papulovesicular rashes at a median of 3 months after discontinuation of Daclizumab. We propose an unexpected T cell mediated immune reaction as the cause
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Multiple Sclerosis | Neurology